Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence–Based Vascular Severity Score

IMPORTANCE: One of the biggest challenges when using anti–vascular endothelial growth factor (VEGF) agents to treat retinopathy of prematurity (ROP) is the need to perform long-term follow-up examinations to identify eyes at risk of ROP reactivation requiring retreatment. OBJECTIVE: To evaluate whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Eilts, Sonja K., Pfeil, Johanna M., Poschkamp, Broder, Krohne, Tim U., Eter, Nicole, Barth, Teresa, Guthoff, Rainer, Lagrèze, Wolf, Grundel, Milena, Bründer, Marie-Christine, Busch, Martin, Kalpathy-Cramer, Jayashree, Chiang, Michael F., Chan, R. V. Paul, Coyner, Aaron S., Ostmo, Susan, Campbell, J. Peter, Stahl, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857423/
https://www.ncbi.nlm.nih.gov/pubmed/36656578
http://dx.doi.org/10.1001/jamanetworkopen.2022.51512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857423/
https://www.ncbi.nlm.nih.gov/pubmed/36656578
http://dx.doi.org/10.1001/jamanetworkopen.2022.51512

Ejemplares similares